Copernicus Therapeutics

Copernicus Therapeutics is a leader in the emerging field of “nano” nucleic acid therapeutics and delivery systems.  The Company’s proprietary platform technology enables new classes of therapeutic agents for the safe and efficient delivery of DNA, RNA, and shRNA.

Funding: Bio Asia, Veron International, Cystic Fibrosis Foundation, GeneChem Management

Stage: Clinical

News: A Noninvasive Avenue for Parkinson's disease Gene Therapy